Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1219, pseudogene (RNU6-1219P) is a non-protein coding pseudogene related to U6 small nuclear RNA (snRNA), which itself is a highly conserved component of the spliceosome that catalyzes pre-mRNA splicing in eukaryotes[1][3]. RNU6-1219P, as a pseudogene, is not known to produce a functional transcript or protein, nor to participate directly in spliceosomal activity or cellular regulation. While U6 snRNA and its active genes are essential for viability and gene expression, pseudogenes like RNU6-1219P typically do not encode functional RNAs and lack therapeutic or biomarker utility[1][3][5]. There is no evidence in the current literature of RNU6-1219P functioning as a drug target, disease marker, or regulatory RNA[5]. Note: While some pseudogenes participate in regulatory RNA processes (such as acting as competing endogenous RNAs)[4], this has not been shown for RNU6-1219P specifically. Key Guidance: - The name refers to a pseudogene, not to an active or therapeutic target. - There are thousands of such U6 snRNA-derived pseudogenes in the human genome, generally without functional or clinical significance[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1219, pseudogene (RNU6-1219P).